Yahoo Finance ( CYBR ) Next Earnings Date: 5-Nov-15
Business Finance News
Netflix, Inc. (NFLX) Expected To Report Above Expected Earnings For Q3FY15
Published by Sam Hason on October 12, 2015
Netflix, Inc. (NASDAQ:NFLX) is scheduled to report 3QFY15 results on October 14, 2015. The company is expected to post strong results with an impressive growth in both international and the US market, due to the recent launches in new territories.
Advaxis Cancer Immunotherapy on Hold Due to Patient Death
| 10/06/15 - 05:07 PM EDT
PRINCETON, N.J. ( TheStreet) -- The U.S. Food and Drug Administration placed a halt on clinical trials involving a cancer immunotherapy from Advaxis (ADXS) because of concerns a bacteria used to deliver the drug may have contributed to a patient death.
Advaxis believes the patient died due to the progression of cervical cancer, but FDA is asking for additionalinformation to confirm the company's experimental therapy, axalimogene filolisbac, played no role. Until the FDA's concerns are resolved, four clinical trials involving Advaxis' axalimogene filolisbac are on clinical hold.
thanks. With that close looks like she wants to run bad.
Im in boys
NFLX is expanding to complete its 200-country takeover by 2016,APPL Talking Yrs Away